1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with sotalol in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (sotalol) | Trials (sotalol) | Recent Studies (post-2010) (sotalol) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 2,196 | 346 | 291 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | sotalol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 3.8169 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 7.1087 | |
| Beta-3 adrenergic receptor | Homo sapiens (human) | 7.2 | |
| Beta-2 adrenergic receptor | Canis lupus familiaris (dog) | 5.0667 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamata, K; Kasuya, Y; Mori, T; Shigenobu, K | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and sotalol
| Article | Year |
|---|---|
Platelet-activating factor: lack of direct action on guinea pig myocardium and possible transmitter release from cardiac sympathetic nerve endings at high concentrations.
Topics: Action Potentials; Animals; Electrophysiology; Guinea Pigs; Heart; In Vitro Techniques; Isoproterenol; Lysophosphatidylcholines; Male; Myocardium; Neurons; Neurotransmitter Agents; Papillary Muscles; Platelet Activating Factor; Reserpine; Sotalol; Sympathetic Nervous System | 1989 |